Vortioxetine Reduces Marble Burying but Only Transiently Enhances Social Interaction Preference in Adult Male BTBR T+Itpr3tf/J Mice
- 30 August 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 10 (10) , 4319-4327
Abstract
Vortioxetine is a multimodal antidepressant with agonist activity at serotonin (5-HT)1A and 5-HT1B receptors that blocks the 5-HT transporter (SERT). Previously in male BTBR T+Itpr3tf/J (BTBR) mice the 5-HT1A agonist buspirone and SERT blocker fluoxetine enhanced social interaction but didn’t reduce marble burying. We hypothesized vortioxetine, through SERT and 5-HT1A could improve BTBR sociability, and via 5-HT1B could reduce burying better than a selective SERT blocker. Vortioxetine (5-10 mg/kg) or sertraline (2 mg/kg) were administered 50 min pre-sociability and 75 min pre-marble burying tests. Vortioxetine (10 mg/kg) occupancy (%) was 84 ± 1 for SERT, 31 ± 12 for 5-HT1A and 80 ± 5 for 5-HT1B in brain at 110 min post-injection, and serum oxytocin was 24% lower (p < 0.01) in vortioxetine-treated mice. Vortioxetine enhanced social sniffing, whereas sertraline enhanced overall sociability. However, the vortioxetine-induced increase in social sniffing was transient, as it was lost with 30 – 60 min pre-test delays in subsequent experiments. Vortioxetine, and sertraline reduced BTBR marble burying. Based on vortioxetine occupancy SERT and/or 5-HT1B are more likely to underlie these effects than 5-HT1A occupancy. Overall, vortioxetine has great potential for suppressing restrictive-repetitive behaviors, but appears less promising as a sociability enhancer.Keywords
Funding Information
- Max and Minnie Tomerlin Voelcker Fund
- Congressionally Directed Medical Research Programs (AR110109)
- National Institute of Mental Health (MH086708)
- Lindow, Stephens and Treat
- Summer Physiology Research Program
This publication has 59 references indexed in Scilit:
- 5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism modelInternational Journal of Neuropsychopharmacology, 2013
- The BTBR Mouse Model of Autism Spectrum Disorders Has Learning and Attentional Impairments and Alterations in Acetylcholine and Kynurenic Acid in Prefrontal CortexPLOS ONE, 2013
- Pharmacokinetic-Pharmacodynamic Modeling of the D2 and 5-HT2A Receptor Occupancy of Risperidone and Paliperidone in RatsPharmaceutical Research, 2012
- Animal models of obsessive-compulsive disorder: Exploring pharmacology and neural substratesNeuroscience & Biobehavioral Reviews, 2012
- Networking in Autism: Leveraging Genetic, Biomarker and Model System Findings in the Search for New TreatmentsNeuropsychopharmacology, 2011
- Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behaviorJournal of Neurochemistry, 2010
- Repetitive Self-Grooming Behavior in the BTBR Mouse Model of Autism is Blocked by the mGluR5 Antagonist MPEPNeuropsychopharmacology, 2009
- Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxietyPsychopharmacology, 2009
- The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorderNeuroscience Letters, 2007
- Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strainsBehavioural Brain Research, 2007